SLC1A2 and epilepsy: The Western blot results showed that EAAT2 expression in the SB203580 group at 3 d after seizure onset was significantly higher than that in the epilepsy group (P < 0.05), and no significant difference in EAAT2 expression was found between the solvent control group and the epilepsy group at this time point (P > 0.05) (Figure 5).